Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease

European Journal of Preventive Cardiology

Volumn 10, Issue 6, 2003, Pages 429-437

  Otterstad, Jan Erik ^a  

^a The Vestfold Heartcare Study Group   (United States)

Author keywords

coronary heart disease; lifestyle intervention; secondary prevention

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SATURATED FATTY ACID; STATIN; WARFARIN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL INTAKE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; EXERCISE; FEMALE; FOLLOW UP; HEART REHABILITATION; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; NURSE; OUTPATIENT; PATIENT EDUCATION; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; RISK REDUCTION; SMOKING CESSATION; SUGAR INTAKE;

BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL; CHOLESTEROL, DIETARY; CORONARY DISEASE; COUNSELING; DIET, FAT-RESTRICTED; DIETARY SUCROSE; EXERCISE; FATTY ACIDS; FEMALE; FOLLOW-UP STUDIES; HEALTH BEHAVIOR; HOSPITALIZATION; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; NORWAY; NURSE-PATIENT RELATIONS; PATIENT COMPLIANCE; RISK FACTORS; SMOKING CESSATION;

EID: 4344658535     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/01.hjr.0000107024.38316.6a     Document Type: Article

References (21)

1. Campbell NC, Thain J, Deans HG, Ritchie LD, Rawles JM. Secondary prevention clinics for coronary heart disease: randomised trial of effect on health. BMJ 2003; 316: 1424–1427.
2. Murchie P, Campbell NC, Ritchie LD, Simpson JA, Thain J. Secondary prevention clinics for coronary heart disease: four year follow up of a randomised controlled trial in primary care. BMJ 2003; 326: 84–87.
3. The West of Scotland Coronary Prevention Study Group. Baseline risk factors and their association with outcome in the West of Scotland Coronary Prevention Study. Am J Cardiol 1997; 79: 756–762.
4. Bjartveit K, Wøien G. Cardiovascular disease risks factors in Norway. Oslo: National Health Screening Service; 1997. pp. 43–46.
5. Nes M, Frost Andersen L, Solvoll K, et al. Accuracy of a quantitative food frequency questionnaire applied in elderly Norwegian women. Eur J Clin Nutr 1992; 46: 809–821.
6. Andersen LF, Solvoll K, Johansson LRK, Salminen I, Aro A, Drevon C.A. Evaluation of a food frequency questionnaire with weighed records, fatty acids and alpha-tocopherol in adipose tissue and serum. Am J Epidemiol 1990; 150: 75–87.
7. Pyorala K, DeBacker G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994; 15: 1300–1331.
8. Wood D, DeBacker G, Faegerman O, Graham I, Mancia G, Pyorala K. Recommendations of the Second Joint Task Force of European and other Societies of coronary prevention. Prevention of coronary heart disease in clinical practice. Eur Heart J 1998; 19: 1434–1503.
9. Gianuzzi P, Saner H, Bjørnstad H, et al. Secondary prevention through cardiac rehabilitation. Position paper of the working group on cardiac rehabilitation and exercise physiology of the European Society of Cardiology. Eur Heart J 2003; 24: 1273–1278.
10. Johnson LK. Dietary changes in patients with coronary heart disease. Thesis for Master of Science. Johan Throne Holst's Institute for Nutrition Research, Faculty of Medicine, University of Oslo 2001.
11. Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med 1970; 2: 92–98.
12. Wasenius A, Stugaard M, Otterstad JE, Frøyshov D. Diurnal and monthly intra-individual variability of the concentration of lipids, lipoproteins and apoproteins. Scand J Clin Lab Invest 1990; 50: 635–542.
13. Hjermann I. Effect of diet and smoking intervention on the incidence of coronary heart disease. Lancet 1981; 331: 1303–1310.
14. de Lorgeril M, Raynaud S. Mediterranean alpha-linoleic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994; 343: 1454–1459.
15. Oldridge NB, Guyatt GH, Fischer ME, Rimm AA. Cardiac rehabilitation after myocardial infarction: combined experience of randomised clinical trials. JAMA 1988; 260: 945–950.
16. O'Connor GT, Buring JE, Yusuf S, et al. An overview of randomised trials of rehabilitation with exercise after myocardial infarction. Circulation 1989; 80: 234–244.
17. Ades PA. Review article. Cardiac rehabilitation and secondary prevention of coronary hear disease. N Engl J Med 2001; 345: 892–902.
18. WHO Technical Report Series 831. Rehabilitation after cardiovascular diseases, with special emphasis on developing countries. World Health Organisation Geneva; 1993.
19. Anderssen SA. The Oslo diet and exercise study. Effect diet and exercise upon risk factors for cardiovascular disease. A one-year randomised controlled study. The Norwegian University of Sports and exercise (thesis); 1997.
20. Marchioli R, Avanzini F, Barzi F, et al. Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations. GISSI-prevenzione mortality risk chart. Eur Heart J 2001; 22: 2085–2103.
21. Dàgostino RB, Russel MW, Huse D, et al. Primary and subsequent coronary risk appraisal: new results from The Framingham Study. Am Heart J 2000; 139: 272–281.